Patient examples from LIBTAYO trials

LIBTAYO achieved results you can see.

Below are examples of results from 3 patients who responded to treatment in clinical trials with LIBTAYO. Individual patient responses may vary.

Patient example 1

This is an example from the 30% (58 out of 193 patients) of patients who saw tumors shrink (partial response) in 1 clinical trial with LIBTAYO.

Pictured below is an ear tumor from a 57-year-old male patient.

He had CSCC that could not be cured by surgery or radiation.

Before starting treatment

Image of an ear tumor, before starting treatment, in a patient with advanced CSCC that could not be cured by surgery or radiation

After 24 weeks (6 months) on LIBTAYO

After 24 weeks of treatment: Image of an ear tumor in a patient with advanced CSCC that could not be cured by surgery or radiation

After 32 weeks (8 months) on LIBTAYO

After 32 weeks of treatment: Image of an ear tumor in a patient with advanced CSCC that could not be cured by surgery or radiation

After 88 weeks (21 months) on LIBTAYO

After 88 weeks of treatment: Image of an ear tumor in a patient with advanced CSCC that could not be cured by surgery or radiation

This patient had a response that lasted approximately 20 months. At the time of data collection, 26 months (3 months after completing treatment with LIBTAYO as per the study plan), the patient's disease had worsened (image not available).

Patient example 2

This is an example from the 30% (58 out of 193 patients) of patients who saw tumors shrink (partial response) in 1 clinical trial with LIBTAYO.

Pictured below is a neck tumor from an 85-year-old male patient.

He had CSCC that had spread, or metastasized, to other parts of the body.

Before starting treatment

Image of a neck tumor, before starting treatment, in a patient with advanced CSCC that could not be cured by surgery or radiation

After 8 weeks (2 months) on LIBTAYO

After 8 weeks of treatment: Image of a neck tumor in a patient with advanced CSCC that could not be cured by surgery or radiation

After 24 weeks (6 months) on LIBTAYO

After 24 weeks of treatment: Image of a neck tumor in a patient with advanced CSCC that could not be cured by surgery or radiation

After 56 weeks (13 months) on LIBTAYO

After 56 weeks of treatment: Image of a neck tumor in a patient with advanced CSCC that could not be cured by surgery or radiation

This patient had a response that lasted 37+ months. At the time of data collection, 39 months (16 months after completing treatment with LIBTAYO as per the study plan), the patient's response was still ongoing (image not available).

Patient example 3

This is an example from the 17% (33 out of 193 patients) of patients who saw tumors completely disappear (complete response) in 1 clinical trial with LIBTAYO.

Pictured below are chest lesions from a 66-year-old male patient.

He had CSCC that had spread, or metastasized, to other parts of his body.

Before starting treatment

Image of a neck tumor, before starting treatment, in a patient with advanced CSCC that had spread

After 8 weeks (2 months) on LIBTAYO

After 8 weeks of treatment: Image of a neck tumor in a patient with advanced CSCC that had spread

After 24 weeks (6 months) on LIBTAYO

After 24 weeks of treatment: Image of a neck tumor in a patient with advanced CSCC that had spread

After 64 weeks (15 months) on LIBTAYO

After 64 weeks of treatment: Image of a neck tumor in a patient with advanced CSCC that had spread

This patient had a response that lasted 31+ months. At the time of data collection, 37 months (14 months after completing treatment with LIBTAYO as per the study plan), the patient's response was still ongoing (image not available).

Review the most important safety information you should know about LIBTAYO.

Learn more